Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Best e-Business Site, 2006
Best e-Business Site, 2007
Amazon’s Alexa 2008 PageRank: #2 News and Media Site for the Pharmaceutical Industry
Google 2008 PageRank: #3 Among Top Health News and Media Publications
NewsRx also is available at Factiva, LexisNexis, ProQuest, Westlaw, Dialog, NewsEdge, InfoDesk, and Dow Jones.

Medical News Article on Biologics



Raven biotechnologies Advances RAV18 Through Agreement With CMC ICOS Biologics



2008 MAR 24 -- Raven biotechnologies, inc., a privately held company focused on the discovery and development of monoclonal antibody therapeutics (MAbs) for cancer, and CMC ICOS Biologics, Inc. a leading contract manufacturing organization, announced they have entered into an agreement under which CMC ICOS will create a production cell line for Raven's next IND candidate, RAV18.

RAV18 is a humanized antibody targeting the ADAM9 protein on cells. ADAM9 is expressed on many solid tumors and is thought to contribute to disease progression and metastasis. A number of carcinoma cell lines have been shown to amplify the gene for ADAM9 and to overexpress the protein....

In order to view the entire article, please read your options to the right

Price: $3.00


NewsRx Customer? If you have an account with NewsRx and have purchased either a NewsRx Bundled package or a NewsRx Pass, you can log into your account below to access this article.

Email:
Password:

New to NewsRx? If you are new to NewsRx, you may also take advantage of cost-saving options such as those below to view this article.

Purchase a NewsRx Pass
View an unlimited number of articles for a day, week, month, etc.

Purchase NewsRx Bundled
Purchase a bundle of article-viewing-credits that never expire and receive a discount of up to 50%!